Artrya Limited (ASX:AYA)

Australia flag Australia · Delayed Price · Currency is AUD
1.950
-0.090 (-4.41%)
Aug 28, 2025, 3:59 PM AEST
-4.41%
Market Cap229.40M
Revenue (ttm)28.00K
Net Income (ttm)-16.41M
Shares Out117.64M
EPS (ttm)-0.18
PE Ration/a
Forward PE16.25
Dividendn/a
Ex-Dividend Daten/a
Volume535,785
Average Volume767,890
Open2.070
Previous Close2.040
Day's Range1.905 - 2.070
52-Week Range0.250 - 2.250
Beta0.20
RSI71.24
Earnings DateJul 28, 2025

About Artrya

Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans which identifies and manages patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia. [Read more]

Sector Healthcare
Founded 2018
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol AYA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.